What is a newer prescription combination product for migraine that includes a NSAID and a triptan?

Prepare for the Pharmacology IV – Headache Therapeutics Test. Review the therapeutic approaches, tackle multiple-choice questions with explanations, and boost your test-taking confidence. Ace your exam with precision!

Multiple Choice

What is a newer prescription combination product for migraine that includes a NSAID and a triptan?

Combining a triptan with an NSAID leverages two complementary ways to stop a migraine: the triptan directly narrows cranial blood vessels and dampens trigeminal nerve signaling, while the NSAID reduces inflammation by blocking prostaglandin production. This dual approach can provide faster relief and lower the chance of the headache returning. A newer fixed-dose product that fits this concept is Treximet, which pairs sumatriptan (a triptan) with naproxen (an NSAID). Sumatriptan targets 5-HT1B/1D receptors to cause vasoconstriction and inhibit neuropeptide release, while naproxen reduces prostaglandin-mediated inflammation. Using them together combines rapid onset with anti-inflammatory action, often improving overall efficacy for acute migraine. Treximet is approved for acute treatment in adults and in pediatric patients 12 years and older, with dosing designed for a single at-once intake at the start of a migraine attack. The other options listed involve either a single-trip tan medication or suggest a combination that isn’t a standard marketed fixed-dose product, so they don’t reflect the newer NSAID-plus-triptan approach in a single tablet.

Combining a triptan with an NSAID leverages two complementary ways to stop a migraine: the triptan directly narrows cranial blood vessels and dampens trigeminal nerve signaling, while the NSAID reduces inflammation by blocking prostaglandin production. This dual approach can provide faster relief and lower the chance of the headache returning.

A newer fixed-dose product that fits this concept is Treximet, which pairs sumatriptan (a triptan) with naproxen (an NSAID). Sumatriptan targets 5-HT1B/1D receptors to cause vasoconstriction and inhibit neuropeptide release, while naproxen reduces prostaglandin-mediated inflammation. Using them together combines rapid onset with anti-inflammatory action, often improving overall efficacy for acute migraine. Treximet is approved for acute treatment in adults and in pediatric patients 12 years and older, with dosing designed for a single at-once intake at the start of a migraine attack.

The other options listed involve either a single-trip tan medication or suggest a combination that isn’t a standard marketed fixed-dose product, so they don’t reflect the newer NSAID-plus-triptan approach in a single tablet.

More practice questions